Market Overview

The Global Intragastric Balloon Market size was valued at USD 44.81 Million in 2023 and is projected to grow from USD 51.22 Million in 2024 to USD 149.21 Million by 2032, exhibiting a CAGR of 14.3% during the forecast period.

The Forecast Period of Intragastric Balloon Market:

The global intragastric balloon market is growing rapidly, largely because of the rising incidence of obesity and the increased demand for minimally invasive weight loss procedures. An intragastric balloon is a non-surgical, temporary device that can be placed in the stomach to provoke weight loss by creating an inability to eat or a feeling of satiety. These balloons are filled with saline or gas and remain in the stomach for six months to a year before they are removed. They have gained popularity because they are less invasive than bariatric surgeries, like gastric bypass or sleeve gastrostomy, which are more risky and invasive procedures.

The utilization of intragastric inflatables as a weight reduction device has expanded because of developing information on the negative wellbeing impacts of corpulence, like coronary illness, type 2 diabetes, and hypertension. Request is likewise being moved by the developing accentuation on wellbeing and prosperity, which is being filled by taxpayer supported initiatives and clinical missions that feature the benefits of keeping a sound weight. Intragastric inflatables are a suitable option for patients searching for less meddling weight reduction techniques, especially for the people who are not contender for medical procedure or who would prefer to utilize non-long-lasting fixes.

Technological advancements in balloon design and materials have also helped in the growth of the market. The newer generation balloons are safer, more durable, and easier to place and remove, thus providing greater comfort and better outcomes for the patient. Moreover, swallow able, capsule-based intragastric balloons have made the procedure less complicated, thus avoiding the requirement of endoscopic placement and anaesthesia, thereby making the treatment accessible to a larger group of patients.

However, there are some side effects to the market of placing the balloon in the market, including nausea and vomiting, abdominal discomfort. The cost of treatment and the need for follow-up care may also serve as a deterrent to some groups of populations from using this specific treatment. However, this market for intragastric balloons is bound to grow further due to the high prevalence of obesity and the use of non-invasive means of weight loss.

Market Dynamics - Market Drivers

Preference for Minimally Invasive Procedures

Another major influencer is the growing preference among patients for less invasive weight loss procedures over the traditional bariatric surgeries. Today, intragastric balloons are the preferred choice of several patients because it is a reversible, no permanent procedure involving fewer complications as compared with bariatric surgeries that are invasive in nature. Intragastric balloons are safer than bariatric surgeries since they are reversible and temporary procedures with minimal time for recovery.

Rising Obesity Rates

One of the key promoters of the global intragastric balloon market is the rise in the rates of obesity globally. Lifestyles have changed and lifestyles have also changed to include more inactive lifestyles, as well as dietary patterns of poor health. Increased cases of obese complications have included cardiovascular illnesses, type 2 diabetics, and other metabolic diseases. For this reason, the demand to lose weight has become pertinent. Intragastric balloons are a minimally invasive procedure that has gained popularity among those who seek non-surgical alternatives for sustainable weight loss.

Key Findings:

According to WHO

• In 2022, 1 in 8 people in the world were living with obesity.
• Worldwide adult obesity has more than doubled since 1990, and adolescent obesity has quadrupled.
• In 2022, 2.5 billion adults (18 years and older) were overweight. Of these, 890 million were living with obesity.
• In 2022, 43% of adults aged 18 years and over were overweight and 16% were living with obesity.
• In 2022, 37 million children under the age of 5 were overweight.
• Over 390 million children and adolescents aged 5–19 years were overweight in 2022, including 160 million who were living with obesity.

Market Opportunities

Technological Advancements in Balloon Design

On-going technological advancement for an intragastric balloon provides scope for a vast market. Some of the major developments include advancement wherein swallowing balloons that do not require an endoscope for placement and reduce invasiveness thereof are friendlier to the patient, too, as such leads toward their better ability to make room in order to grow market size through such manufactures also.

Growing Demand in Emerging Markets

Asia and Latin American regions offer growth prospects for the intragastric balloon market. With rising health awareness in terms of risks associated with obesity and improved healthcare infrastructure and disposable incomes, demand for weight loss treatments will increase. Besides, increasing access to healthcare and government initiatives on obesity management will also benefit the market.

Market Restraining Factors

High Procedure Costs

However, the procedure using an intragastric balloon is rather expensive and could thus be a strong constraint to adoption, especially in price-sensitive regions. It is normally too costly to afford for many patients, and this constrains the market reach, especially in developing countries where healthcare budgets and personal spending on elective procedures may be constrained.

Potential Side Effects and Complications

The risk of side effects and complications associated with intragastric balloons is also one of the important limitations. Complaints like nausea, vomiting, and abdominal pain would turn many patients away from intragastric balloon surgery. At times, this surgical intervention leads to even more complications in the form of balloon deflation, intestinal blockage, or gastric ulcers in some cases, resulting in the loss of a patient's confidence and more extensive rejection of the treatment procedure as well.

Segmentation Analysis

The market scope is segmented because of by Product Type, by Administration, by Application.

By Product Type

Based on the Product Type of the market is segmented into Single, Dual, Triple.

The single intragastric balloon segment has dominated the global intragastric balloon market among the product types (single, dual, and triple balloons). The main reason for this dominance is that single balloons are a very simple, effective, and widely adopted weight loss solution. Single intragastric balloons have been in use for a longer period than dual and triple balloons, thereby allowing them to gain more clinical acceptance and trust among healthcare providers and patients.

The primary advantage of single balloons is their low cost and relatively simpler insertion procedure than that of the multiple balloon systems. The majority of the time, they are placed endoscopic ally, filled with saline or gas, and remain in the stomach for six months, which provides a safe, non-invasive means to achieve weight loss. Ease of placement and removal, coupled with fewer side effects, have made the segment popular.

In addition, single intragastric balloons are widely recommended for most patients such as those with moderate obesity who seek non-invasive and temporary weight loss solutions. Further, the affordability of safety and efficacy has added a boost to the dominance of the single intragastric balloon in the market. Double and triple balloon systems, though emerging, have benefits of their own, but in the case of both the patient and the healthcare professional, the preferred choice remains a single balloon.

By Administration

Based on the Administration of the market is segmented into Pill, Endoscopy.

The endoscopy segment holds the largest market share of intragastric balloon through the administration method, due mainly to the reason that intragastric balloon endoscopic placement has been the most established and widely accepted technique of intragastric balloon. In an endoscopic procedure, a deflated balloon is inserted into the stomach through the mouth using an endoscope, a flexible tube with a camera, which allows the physician to precisely place the balloon in the desired position. Once it is placed, it is filled with either saline or gas which occupies the stomach space helping patients feel fuller having less food.

The lead of the endoscopy segment comes from the accuracy and control it offers during the procedure. The physician can see visually whether the balloon is in the right position or if it has to be moved to avoid complications that may arise. Also, endoscopy is a relatively well-established technique in clinical practice. The years of safety data combined with successful outcomes have instilled confidence among the healthcare professionals as well as the patients.

Although swallow able, pill-based balloons are becoming increasingly popular because of the non-invasive nature, they are relatively newer in the market. The healthcare providers still prefer endoscopic procedures due to higher safety and control levels and more so for patients who need personalized attention and care during the placement of the balloon.

By Regional Snapshots

By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. North America dominated the global intragastric balloon market. High prevalence of obesity, strong established healthcare systems, and several healthcare professionals offering weight loss solutions can be responsible for this dominance in this region. Awareness about the serious health issues related to obesity, including diabetes, heart disease, and hypertension, have contributed highly to adopting nonsurgical methods of weight loss such as intragastric balloons.

The robust healthcare infrastructure, superior state-of-the-art medical technology in North America, and the relative higher willingness of patients undergoing weight loss procedures support that region's growth in its market. The FDA approvals of a large number of intragastric balloon products also make the same region a key hub for treatments as well as innovation on the weight management solution aspects.

On the other hand, the Asia-Pacific region is expected to be the fastest-growing market for intragastric balloons. This growth is driven by the rising obesity rates in countries such as China, India, and Japan, where sedentary lifestyles and dietary changes are leading to increased health risks. The growing healthcare infrastructure, rising disposable incomes, and improving access to advanced medical treatments are also contributing factors.

The increased awareness of obesity and its complications is going to generate a huge demand for the management of weight through intragastric balloons. The expanding medical tourism industry in the region, especially in Thailand and India, where the procedure is relatively cheaper, will also boost the growth of the market in this region.

List of Companies Profiled

• Endalis
• Spatz Medical
• Silimed Brazil
• Helioscopie
• Medispar NV
• ReShape Medical, Inc.
• Lexel Medical
• Apollo Endosurgery, Inc.
• Obalon Therapeutics, Inc.
• Allurion Technologies, Inc.
• Districlass Medical
• Suzhou Shenyun Medical Equipment Co., Ltd

Key Industry Developments

• Allurion finished enrolling patients in its AUDACITY study in October 2023. The study is a critical trial intended to help the U.S. FDA approve the company's gastric balloon.
• ReShape Lifesciences, Inc. and Biorad Medisys, Pvt. Ltd. (Biorad) signed a royalty-bearing license agreement in September 2023 for the development, marketing, and distribution of Obalon gastric balloons in Pakistan, India, Nepal, Sri Lanka, and other Asia Pacific nations. The corporation wanted to increase its footprint in emerging countries with this deal.

Report Coverage

The report will cover the qualitative and quantitative data on the global Intragastric Balloon Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.

Report Scope and Segmentations

Regional Analysis

North America accounted for the highest xx% market share in terms of revenue in the Intragastric Balloon market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Intragastric Balloon. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Intragastric Balloon companies in economies such as Japan and China.

The objective of the report is to present comprehensive analysis of Global Intragastric Balloon Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

Intragastric Balloon Market Report is also available for below Regions and Country Please Ask for that

North America

• U.S.
• Canada

Europe

• Switzerland
• Belgium
• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Rest of Europe

Asia-Pacific

• India
• Australia
• Philippines
• Singapore
• South Korea
• Japan
• China
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Argentina
• Peru
• Colombia
• Brazil
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Points Covered in the Report

• The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 12 years data history and forecast.
• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
• Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
• The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase

• To gain insightful analyses of the Intragastric Balloon market and have comprehensive understanding of the global market and its commercial landscape.
• Assess the production processes, major issues, and solutions to mitigate the development risk.
• To understand the most affecting driving and restraining forces in the market and its impact in the global market.
• Learn about the Intragastric Balloon market strategies that are being adopted by leading respective organizations.
• To understand the future outlook and prospects for the Intragastric Balloon market. Besides the standard structure reports, we also provide custom research according to specific requirements.

Research Scope of Intragastric Balloon Market

• Historic year: 2019-2022
• Base year: 2023
• Forecast: 2024 to 2032
• Representation of Market revenue in USD Million

Intragastric Balloon Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: